In addition, there is evidence indicating the role of the FOXA1 gene in the development of chemoresistance and the existence of a FOXA1-positive chemotherapy refractory triple-negative breast cancer (TNBC) subtype [20,21,22]. This evidence concerns the gene FOXA1 and triple-negative breast carcinoma.